
Spruce Biosciences, Inc.
SPRBNasdaqCIK 1683553HealthcareFiscal year ends Dec 31
Reports and events: 117 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-03-2821:15 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-081224 |
| 2024-03-2521:48 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-076792 |
| 2024-03-2021:31 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-073032 |
| 2024-03-1821:16 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-070413 |
| 2024-03-1816:05 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-032819 |
| 2024-03-1316:12 ET | 8-K | 2.02 Results of operations; 2.05 Exit or disposal costs; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-030776 |
| 2024-03-0716:07 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-062172 |
| 2024-01-0808:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-002704 |
| 2023-11-1316:22 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-062997 |
| 2023-11-1316:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-062936 |
| 2023-08-1416:20 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-042439 |
| 2023-08-1416:12 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-042420 |
| 2023-05-3016:48 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-23-156667 |
| 2023-05-2616:12 ET | 8-K | 5.07 Shareholder vote results | 0000950170-23-024515 |
| 2023-05-2508:16 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-23-024071 |
| 2023-05-1508:20 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-021984 |
| 2023-05-1508:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-021979 |
| 2023-04-0516:10 ET | DEF 14A | Proxy statementPeriod 2023-05-25 | 0000950170-23-011910 |
| 2023-03-1616:11 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-008456 |
| 2023-03-1616:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-008448 |
| 2023-02-2316:15 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-23-046574 |
| 2023-02-2116:28 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-23-043535 |
| 2023-02-1316:16 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-23-035842 |
| 2023-02-0916:33 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0000950170-23-002369 |
| 2023-01-0908:15 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-000449 |
| 2022-12-0217:27 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0000950170-22-026009 |
| 2022-11-1016:33 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000950170-22-024531 |
| 2022-11-1016:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-024479 |
| 2022-09-3016:54 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-22-255669 |
| 2022-08-1116:50 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-22-218641 |
| 2022-08-1016:22 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000950170-22-016486 |
| 2022-08-1016:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-016467 |
| 2022-05-2716:14 ET | 8-K | 5.07 Shareholder vote results | 0000950170-22-010856 |
| 2022-05-1116:13 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0000950170-22-009335 |
| 2022-05-1116:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-009312 |
| 2022-04-0817:27 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-22-005528 |
| 2022-04-0716:49 ET | DEF 14A | Proxy statementPeriod 2022-05-25 | 0001140361-22-013615 |
| 2022-03-1416:35 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-22-003590 |
| 2022-03-1416:26 ET | 10-K | Annual reportPeriod 2021-12-31 | 0000950170-22-003582 |
| 2022-03-1416:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-003573 |
| 2022-01-0517:04 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001564590-22-000432 |
| 2021-11-2216:08 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-21-336766 |
| 2021-11-1516:24 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001564590-21-057024 |
| 2021-11-1516:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-21-057008 |
| 2021-09-1509:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-21-047979 |
| 2021-08-2511:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-21-045641 |
| 2021-08-1016:23 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001564590-21-043111 |
| 2021-08-1016:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-21-043089 |
| 2021-06-2916:12 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001564590-21-035079 |
| 2021-05-2416:37 ET | 8-K | 5.07 Shareholder vote results | 0001564590-21-029534 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 9, 2026, 17:52 ET. Listed shows no prices and gives no investment advice.